An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Public ClinicalTrials.gov record NCT02869789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b/4 Safety Trial of Flat Dose Nivolumab In Combination With Ipilimumab in Participants With Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the safety of Nivolumab given in combination with Ipilimumab in patients with advanced cancers. The initial group will enroll patients with newly diagnosed Stage 4 or non-small cell lung cancer that has come back.
Study identification
- NCT ID
- NCT02869789
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,041 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 5, 2016 (Actual)
- Primary completion
- May 13, 2022 (Actual)
- Completion
- May 13, 2022 (Actual)
- Last update posted
- Jun 15, 2023
2016 – 2022
United States locations
- U.S. sites
- 61
- U.S. states
- 26
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0121 | Birmingham | Alabama | 35205 | — |
| Local Institution - 0148 | Phoenix | Arizona | 85016 | — |
| Local Institution - 0085 | Tucson | Arizona | 85704 | — |
| Local Institution - 0164 | Little Rock | Arkansas | 72205 | — |
| Local Institution - 0146 | Bakersfield | California | 93309 | — |
| Marin Cancer Care, Inc | Greenbrae | California | 94904 | — |
| Los Angeles Hematology/Oncology Medical Group | Los Angeles | California | 90017 | — |
| Local Institution - 0115 | Los Angeles | California | 90095 | — |
| Torrance Health Association | Redondo Beach | California | 90277 | — |
| Va San Diego Healthcare System | San Diego | California | 92161 | — |
| Local Institution - 0143 | San Luis Obispo | California | 93401 | — |
| Local Institution - 0144 | Santa Maria | California | 93454 | — |
| Gene Upshaw Memorial Tahoe Forest Cancer Center | Truckee | California | 96161 | — |
| Local Institution - 0161 | Whittier | California | 90603 | — |
| Local Institution - 0083 | Denver | Colorado | 80218 | — |
| Local Institution - 0141 | Grand Junction | Colorado | 81501 | — |
| Cancer Specialists of North FL | Jacksonville | Florida | 32207 | — |
| Local Institution - 0082 | Ocala | Florida | 34474 | — |
| Local Institution - 0147 | Pembroke Pines | Florida | 33028 | — |
| Local Institution - 0163 | Athens | Georgia | 30607 | — |
| Local Institution - 0002 | Atlanta | Georgia | 30322 | — |
| Local Institution - 0166 | Atlanta | Georgia | 30342 | — |
| Local Institution - 0088 | Niles | Illinois | 60714 | — |
| Local Institution - 0108 | Wichita | Kansas | 67214 | — |
| Kentucky One Health St. Joseph East Cancer Center | Lexington | Kentucky | 40509 | — |
| Local Institution - 0091 | Columbia | Maryland | 21044 | — |
| Local Institution - 0089 | Edina | Minnesota | 55435-2150 | — |
| Jackson Oncology Associates, Pllc | Jackson | Mississippi | 39202 | — |
| Local Institution - 0077 | Grand Island | Nebraska | 68803 | — |
| Local Institution - 0087 | Las Vegas | Nevada | 89148 | — |
| Local Institution - 0170 | Reno | Nevada | 89511 | — |
| Local Institution - 0156 | Belleville | New Jersey | 07109 | — |
| Summit Medical Group | Florham Park | New Jersey | 07932 | — |
| Local Institution - 0142 | Livingston | New Jersey | 07039 | — |
| Local Institution - 0167 | The Bronx | New York | 10461 | — |
| Local Institution - 0004 | Durham | North Carolina | 27710 | — |
| Local Institution - 0012 | Winston-Salem | North Carolina | 27157 | — |
| Local Institution - 0100 | Cincinnati | Ohio | 45242 | — |
| Local Institution - 0134 | Cleveland | Ohio | 44109 | — |
| Local Institution - 0172 | Corvallis | Oregon | 97330 | — |
| Local Institution - 0096 | Eugene | Oregon | 97401 | — |
| Local Institution - 0176 | Portland | Oregon | 97239 | — |
| Local Institution - 0139 | Allentown | Pennsylvania | 18103 | — |
| Allegheny Health Network | Pittsburgh | Pennsylvania | 15224 | — |
| Local Institution - 0159 | Pittsburgh | Pennsylvania | 15232 | — |
| Local Institution - 0001 | Sayre | Pennsylvania | 18840 | — |
| Local Institution - 0123 | Charleston | South Carolina | 29414 | — |
| Local Institution - 0066 | Chattanooga | Tennessee | 37404 | — |
| Local Institution - 0067 | Nashville | Tennessee | 37203 | — |
| Local Institution - 0090 | Austin | Texas | 78745 | — |
| Texas Oncology, P.A. | Dallas | Texas | 75230 | — |
| Local Institution - 0149 | Dallas | Texas | 75231 | — |
| Local Institution - 0094 | Fort Worth | Texas | 76104 | — |
| Local Institution - 0093 | Longview | Texas | 75601 | — |
| Local Institution - 0098 | Plano | Texas | 75075-7787 | — |
| Local Institution - 0086 | Waco | Texas | 76712 | — |
| Local Institution - 0097 | Fairfax | Virginia | 22031 | — |
| Local Institution - 0044 | Richmond | Virginia | 23230 | — |
| Providence Regional Cancer Partnership | Everett | Washington | 98201 | — |
| Local Institution - 0174 | Renton | Washington | 98055 | — |
| Local Institution - 0173 | Spokane | Washington | 99208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02869789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2023 · Synced Oct 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02869789 live on ClinicalTrials.gov.